TNSN07227A1 - Derives de chromane utiles comme antagonistes de la pompe a acide - Google Patents
Derives de chromane utiles comme antagonistes de la pompe a acideInfo
- Publication number
- TNSN07227A1 TNSN07227A1 TNP2007000227A TNSN07227A TNSN07227A1 TN SN07227 A1 TNSN07227 A1 TN SN07227A1 TN P2007000227 A TNP2007000227 A TN P2007000227A TN SN07227 A TNSN07227 A TN SN07227A TN SN07227 A1 TNSN07227 A1 TN SN07227A1
- Authority
- TN
- Tunisia
- Prior art keywords
- compounds
- treatment
- acid pump
- disease
- pharmaceutically acceptable
- Prior art date
Links
- 239000002253 acid Substances 0.000 title abstract 2
- 239000005557 antagonist Substances 0.000 title abstract 2
- 150000001843 chromanes Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 201000006549 dyspepsia Diseases 0.000 abstract 3
- 208000021302 gastroesophageal reflux disease Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 208000019505 Deglutition disease Diseases 0.000 abstract 1
- 208000007882 Gastritis Diseases 0.000 abstract 1
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
- 206010019375 Helicobacter infections Diseases 0.000 abstract 1
- 206010028813 Nausea Diseases 0.000 abstract 1
- 206010030216 Oesophagitis Diseases 0.000 abstract 1
- 208000008469 Peptic Ulcer Diseases 0.000 abstract 1
- 206010039424 Salivary hypersecretion Diseases 0.000 abstract 1
- 208000008630 Sialorrhea Diseases 0.000 abstract 1
- 208000007107 Stomach Ulcer Diseases 0.000 abstract 1
- 208000025865 Ulcer Diseases 0.000 abstract 1
- 201000008629 Zollinger-Ellison syndrome Diseases 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 208000010643 digestive system disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 208000000718 duodenal ulcer Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000003628 erosive effect Effects 0.000 abstract 1
- 201000005917 gastric ulcer Diseases 0.000 abstract 1
- 201000000052 gastrinoma Diseases 0.000 abstract 1
- 208000029493 gastroesophageal disease Diseases 0.000 abstract 1
- 208000018685 gastrointestinal system disease Diseases 0.000 abstract 1
- 208000024798 heartburn Diseases 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000008693 nausea Effects 0.000 abstract 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 abstract 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 abstract 1
- 208000011906 peptic ulcer disease Diseases 0.000 abstract 1
- 231100000397 ulcer Toxicity 0.000 abstract 1
- 208000009935 visceral pain Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63696304P | 2004-12-17 | 2004-12-17 | |
| US69577205P | 2005-06-29 | 2005-06-29 | |
| PCT/IB2005/003758 WO2006064339A1 (en) | 2004-12-17 | 2005-12-07 | Chromane derivatives useful as acid pump antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TNSN07227A1 true TNSN07227A1 (fr) | 2008-11-21 |
Family
ID=35995811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2007000227A TNSN07227A1 (fr) | 2004-12-17 | 2007-06-15 | Derives de chromane utiles comme antagonistes de la pompe a acide |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20090291977A1 (https=) |
| EP (1) | EP1838309B1 (https=) |
| JP (1) | JP2008524199A (https=) |
| KR (1) | KR20070086294A (https=) |
| AP (1) | AP2007004023A0 (https=) |
| AT (1) | ATE405262T1 (https=) |
| AU (1) | AU2005315303A1 (https=) |
| BR (1) | BRPI0519598A2 (https=) |
| CA (1) | CA2591412A1 (https=) |
| DE (1) | DE602005009257D1 (https=) |
| EA (1) | EA011512B1 (https=) |
| ES (1) | ES2313444T3 (https=) |
| IL (1) | IL183602A0 (https=) |
| MA (1) | MA29095B1 (https=) |
| MX (1) | MX2007007010A (https=) |
| NO (1) | NO20072764L (https=) |
| TN (1) | TNSN07227A1 (https=) |
| WO (1) | WO2006064339A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007026218A2 (en) * | 2005-09-01 | 2007-03-08 | Pfizer Japan Inc. | Chromane substituted 2-alkyl imidazopyridine derivatives and use thereof as acid pump antagonists |
| JP2009530262A (ja) * | 2006-03-17 | 2009-08-27 | ラクオリア創薬株式会社 | クロマン誘導体 |
| WO2008059373A1 (en) * | 2006-11-17 | 2008-05-22 | Raqualia Pharma Inc. | Imidazo [1, 2-a] pyrazine derivatives and their use as acid pump antagonists |
| DK3071206T3 (da) | 2013-11-22 | 2021-05-25 | CL BioSciences LLC | Gastrinantagonister (eg yf476, netazepid) til behandling og forebyggelse af osteoporose |
| JP6315708B2 (ja) * | 2015-06-22 | 2018-04-25 | 日本電信電話株式会社 | リチウム空気二次電池、リチウム空気二次電池の製造方法及びリチウム空気二次電池を備えた装置 |
| CN121574094A (zh) * | 2026-01-23 | 2026-02-27 | 湖南先施制药有限公司 | 一种瑞巴派特伏诺拉生盐及其制备方法和应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9801526D0 (sv) * | 1998-04-29 | 1998-04-29 | Astra Ab | New compounds |
| SE0102808D0 (sv) * | 2001-08-22 | 2001-08-22 | Astrazeneca Ab | New compounds |
| CA2506027A1 (en) * | 2002-11-19 | 2004-06-03 | Altana Pharma Ag | 8-substituted imidazopyridines |
-
2005
- 2005-12-07 US US11/721,453 patent/US20090291977A1/en not_active Abandoned
- 2005-12-07 ES ES05818222T patent/ES2313444T3/es not_active Expired - Lifetime
- 2005-12-07 MX MX2007007010A patent/MX2007007010A/es unknown
- 2005-12-07 KR KR1020077013608A patent/KR20070086294A/ko not_active Abandoned
- 2005-12-07 EP EP05818222A patent/EP1838309B1/en not_active Expired - Lifetime
- 2005-12-07 WO PCT/IB2005/003758 patent/WO2006064339A1/en not_active Ceased
- 2005-12-07 AU AU2005315303A patent/AU2005315303A1/en not_active Abandoned
- 2005-12-07 DE DE602005009257T patent/DE602005009257D1/de not_active Expired - Fee Related
- 2005-12-07 AT AT05818222T patent/ATE405262T1/de not_active IP Right Cessation
- 2005-12-07 EA EA200701087A patent/EA011512B1/ru not_active IP Right Cessation
- 2005-12-07 BR BRPI0519598-5A patent/BRPI0519598A2/pt not_active IP Right Cessation
- 2005-12-07 AP AP2007004023A patent/AP2007004023A0/xx unknown
- 2005-12-07 JP JP2007546218A patent/JP2008524199A/ja active Pending
- 2005-12-07 CA CA002591412A patent/CA2591412A1/en not_active Abandoned
-
2007
- 2007-05-31 IL IL183602A patent/IL183602A0/en unknown
- 2007-05-31 NO NO20072764A patent/NO20072764L/no not_active Application Discontinuation
- 2007-06-15 TN TNP2007000227A patent/TNSN07227A1/fr unknown
- 2007-06-15 MA MA29996A patent/MA29095B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL183602A0 (en) | 2007-09-20 |
| AP2007004023A0 (en) | 2007-06-30 |
| NO20072764L (no) | 2007-07-03 |
| ES2313444T3 (es) | 2009-03-01 |
| CA2591412A1 (en) | 2006-06-22 |
| MX2007007010A (es) | 2007-07-10 |
| EA200701087A1 (ru) | 2008-02-28 |
| EP1838309A1 (en) | 2007-10-03 |
| ATE405262T1 (de) | 2008-09-15 |
| BRPI0519598A2 (pt) | 2009-03-10 |
| EP1838309B1 (en) | 2008-08-20 |
| DE602005009257D1 (de) | 2008-10-02 |
| WO2006064339A1 (en) | 2006-06-22 |
| AU2005315303A1 (en) | 2006-06-22 |
| EA011512B1 (ru) | 2009-04-28 |
| KR20070086294A (ko) | 2007-08-27 |
| JP2008524199A (ja) | 2008-07-10 |
| MA29095B1 (fr) | 2007-12-03 |
| US20090291977A1 (en) | 2009-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TNSN07227A1 (fr) | Derives de chromane utiles comme antagonistes de la pompe a acide | |
| FI4148050T3 (fi) | Uusi haponerityksen estäjä ja sen käyttö | |
| TNSN04137A1 (fr) | Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases | |
| KR960704843A (ko) | 5-아릴인돌 유도체 (5-arylindole derivatives) | |
| TNSN05165A1 (fr) | Derives de pyrrolopyrimidine | |
| CA2305548A1 (en) | Prostaglandin agonists and their use to treat bone disorders | |
| KR870008880A (ko) | 방향족 2-아미노알킬-1,2-벤조 이소 티아졸-3(2h)온-1,1-디옥사이드 유도체 | |
| NO20012286D0 (no) | Ny krystallinsk form for omeprazol | |
| ME01598B (me) | Jedinjenja pirola | |
| US5137902A (en) | 4-alkylimidazole derivatives and anti-hypertensive use thereof | |
| TNSN04246A1 (fr) | Derives d'heteroarylamides benzocondenses de thienopyridines utiles comme agents therapeutiques, compositions pharmaceutiques les contenant et methodes pour leur utilisation | |
| US8017784B2 (en) | Substituted sulfoxide compounds, methods for preparing the same and use thereof | |
| KR890008137A (ko) | 3-[4(1-치환된-4-피페라지닐)부틸]-4-티아졸리디노 이의 제조방법 및 약제로서의 이의 용도 | |
| KR20010101699A (ko) | (ｓ)-오메프라졸의 칼륨염 | |
| JP2002030084A5 (https=) | ||
| US7332505B2 (en) | Nitrosated and nitrosylated proton pump inhibitors, compositions and methods of use | |
| CN113620930B (zh) | 一种含磺酰胺结构的化合物及其制备方法和应用、一种药物组合物及应用 | |
| JP2002537336A (ja) | ニトロソ化およびニトロシル化されたプロトンポンプ阻害剤、組成物および使用方法 | |
| CA2065986A1 (en) | 1-(pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1h-indoles, intermediates and a process for their preparation, and their use as medicaments | |
| MA26541A1 (fr) | Nouvelles imidazolines, procede pour les preparer, compositions pharmaceutiques les contenant et leur utilisation dans le traitement de maladies soulagees par un traitement avec un antagoniste des recepteurs des prostaglandines | |
| DE60314105D1 (de) | Alkylammoniumsalze von omeprazol und esomeprazol | |
| PT91198B (pt) | Processo para a preparacao de derivados antiulcera da (alquilditio) quinolina | |
| CA1217485A (fr) | Amino-2 aminomethyl-5 oxazolines-2, leur methode de preparation ainsi que leur application therapeutique | |
| JPH07503023A (ja) | チアゾリルピリジン誘導体およびその胃酸分泌阻害剤としての用途 | |
| IE61945B1 (en) | Antiulcer pyrimidine derivatives |